Guangzhou Baiyunshan Correlations
| GZPHFDelisted Stock | USD 2.88 0.00 0.00% |
The current 90-days correlation between Guangzhou Baiyunshan and Catalent is -0.09 (i.e., Good diversification). The correlation of Guangzhou Baiyunshan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Guangzhou Baiyunshan Correlation With Market
Good diversification
The correlation between Guangzhou Baiyunshan Pharmaceu and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Guangzhou Baiyunshan Pharmaceu and DJI in the same portfolio, assuming nothing else is changed.
Guangzhou |
The ability to find closely correlated positions to Guangzhou Baiyunshan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guangzhou Baiyunshan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guangzhou Baiyunshan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guangzhou Baiyunshan Pharmaceutical to buy it.
Moving together with Guangzhou Pink Sheet
| 0.79 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.66 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.73 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.75 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.8 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.71 | T | ATT Inc Aggressive Push | PairCorr |
Moving against Guangzhou Pink Sheet
| 0.87 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.85 | HLNCF | Haleon plc | PairCorr |
| 0.84 | HLN | Haleon plc | PairCorr |
| 0.76 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.75 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.61 | NSFDF | NXT Energy Solutions | PairCorr |
| 0.6 | ZTLLF | Zonetail | PairCorr |
| 0.51 | TKPHF | Takeda Pharmaceutical | PairCorr |
| 0.47 | VZ | Verizon Communications Aggressive Push | PairCorr |
| 0.91 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.89 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.75 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.63 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.33 | PG | Procter Gamble | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Guangzhou Pink Sheet performing well and Guangzhou Baiyunshan Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Guangzhou Baiyunshan's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CTLT | 0.46 | (0.02) | (0.18) | 0.08 | 0.38 | 1.12 | 3.39 | |||
| ZTS | 0.94 | (0.07) | 0.00 | (0.19) | 0.00 | 1.77 | 6.01 | |||
| ANIP | 1.90 | (0.22) | 0.00 | (0.06) | 0.00 | 3.70 | 10.82 | |||
| CVSI | 4.10 | (0.04) | 0.00 | 0.08 | 6.56 | 25.00 | 45.00 | |||
| RDHL | 3.48 | 0.10 | 0.02 | 0.26 | 3.67 | 9.81 | 29.17 | |||
| AMPH | 1.62 | (0.21) | 0.00 | (0.07) | 0.00 | 3.37 | 17.30 | |||
| DRRX | 3.56 | (0.58) | 0.00 | (16.43) | 0.00 | 8.33 | 21.40 | |||
| LNTH | 2.24 | (0.07) | 0.00 | 0.16 | 0.00 | 3.72 | 27.61 | |||
| CRON | 2.12 | (0.03) | 0.00 | 0.32 | 0.00 | 4.74 | 19.33 |
Guangzhou Baiyunshan Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guangzhou Baiyunshan pink sheet to make a market-neutral strategy. Peer analysis of Guangzhou Baiyunshan could also be used in its relative valuation, which is a method of valuing Guangzhou Baiyunshan by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Guangzhou Baiyunshan Corporate Management
| Xuezhen Huang | Secretary of the Board | Profile | |
| Zhang Chunbo | Deputy Director | Profile | |
| Hong Li | General Manager | Profile | |
| Haoshan Zheng | Deputy General Manager | Profile |
Still Interested in Guangzhou Baiyunshan Pharmaceutical?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.